Implementing opportunistic computed tomography (CT) bone density screening could increase the osteoporosis screening ...

OsteoStrong, the global leader in osteogenic loading technology, is hosting a live webinar featuring CEO Kyle Zagrodzky and biomedical engineer Dr. John Jaquish to discuss newly published research on ...

The global osteoporosis drugs market size was valued at USD 14.90 billion in 2024 and is projected to reach USD 15.39 billion ...

The FDA has approved Stoboclo (denosumab-bmwo), a biosimilar to Prolia (denosumab), and Osenvelt (denosumab-bmwo), a biosimilar to Xgeva (denosumab).

The FDA approved Stoboclo and Osenvelt, denosumab biosimilars that could offer more affordable treatment options for ...

The intrinsic factor of cell senescence, PCBP2, was identified by unlabeled quantitative proteomics, and its biological role in in vitro replication senescence of human bone marrow mesenchymal stromal ...

Get Instant Summarized Text (Gist) Opportunistic CT bone density screening can significantly enhance osteoporosis screening rates, potentially reducing medical costs. Analysis of Medicare data ...

Women with osteoporosis have at least a 50% chance of reaching their target bone mineral density at 3 years if they have a ...

In a study published in a 2024 issue of the American Journal of Obstetrics & Gynecology, researchers predicted that for most ...

To put it another way, women over the age of 45 will spend more days in hospital due to osteoporosis than they will for ...

A new study published in the journal of BMC Gasteroenterology found that patients with the liver cirrhosis had higher risk of ...

To put it another way, women over the age of 45 will spend more days in hospital due to osteoporosis than they will for ...